RESUMO
Expanded access to DNA sequencing now fosters ready detection of site-specific human genome alterations whose actual significance requires in-depth functional study to rule in or out disease-causing mutations. This is a particular concern for genomic sequence differences in glycosyltransferases, whose implications are often difficult to assess. A recent whole-exome sequencing study identifies (c.229 C > T) in the GalNAc-4-ST1 glycosyltransferase (CHST8) as a disease-causing missense R77W mutation yielding the genodermatosis peeling skin syndrome (PSS) when homozygous. Cabral et al. (Genomics. 2012;99:202-208) cite this sequence change as reducing keratinocyte GalNAc-4-ST1 activity, thus decreasing glycosaminoglycan sulfation, as the mechanism for this blistering disorder. Such an identification could point toward potential clinical and/or prenatal diagnosis of a harmful medical condition. However, GalNAc-4-ST1 has minimal activity toward glycosaminoglycans, instead modifying terminal ß1,4-linked GalNAc on N- and O-linked oligosaccharides on specific glycoproteins. We find expression, processing and catalytic activity of GalNAc-4-ST1 completely equivalent between wild type and (R77W) sulfotransferases. Moreover, keratinocytes have little or no GalNAc-4-ST1 mRNA, indicating that they do not express GalNAc-4-ST1. In addition, loss-of-function of GalNAc-4-ST1 primarily presents as reproductive system aberrations rather than skin effects. These findings, an allele frequency of 0.004357, and a 10-fold difference in prevalence of CHST8 (c.299 C > T, R77W) across different ethnic groups, suggest that this sequence represents a "passenger" distributed polymorphism, a simple sequence variant form of the enzyme having normal activity, rather than a "driver" disease-causing mutation that accounts for PSS. This study presents an example for guiding biomedical research initiatives, as well as medical and personal/family perspectives, regarding newly-identified genomic sequence differences.
Assuntos
Dermatite Esfoliativa/genética , Repetições de Microssatélites/genética , Polissacarídeos/genética , Dermatopatias Genéticas/genética , Sulfotransferases/genética , Sequência de Aminoácidos , Animais , Células CHO , Clonagem Molecular , Cricetinae , Cricetulus , Dermatite Esfoliativa/enzimologia , Glicosaminoglicanos/genética , Glicosaminoglicanos/metabolismo , Humanos , Mutação de Sentido Incorreto , Oligossacarídeos/genética , Oligossacarídeos/metabolismo , Polimorfismo Genético , Polissacarídeos/metabolismo , Dermatopatias Genéticas/enzimologia , Sulfotransferases/metabolismoRESUMO
Two closely related ß1,4-N-acetylgalactosaminyltransferases, ß4GalNAc-T3 and ß4GalNAc-T4, are thought to account for the protein-specific addition of ß1,4-linked GalNAc to Asn-linked oligosaccharides on a number of glycoproteins including the glycoprotein hormone luteinizing hormone and carbonic anhydrase-6 (CA6). We have utilized soluble, secreted forms of ß4GalNAc-T3 and ß4GalNAc-T4 to define the basis for protein-specific GalNAc transfer in vitro to chimeric substrates consisting of Gaussia luciferase followed by a glycoprotein substrate. Transfer of GalNAc by ß4GalNAc-T3 and ß4GalNAc-T4 to terminal GlcNAc is divalent cation-dependent. Transfer of GalNAc to glycoprotein acceptors that contain a peptide recognition determinant is maximal between 0.5 and 1.0 mM MnCl(2); however, transfer is increasingly inhibited by concentrations of MnCl(2) above 1 mM and by anion concentrations above 15 mM. In contrast, transfer of GalNAc to the simple sugar acceptor N-acetylglucosamine-ß-p-nitrophenol (GlcNAcß-pNP) is not inhibited by concentrations of MnCl(2) or anions that would inhibit transfer to glycoprotein acceptors by >90%. This finding indicates that interaction with the peptide recognition determinant in the substrate is sensitive to the anion concentration. ß4GalNAc-T3 and ß4GalNAc-T4 have similar but distinct specificities, resulting in a 42-fold difference in the IC(50) for transfer of GalNAc to chimeric glycoprotein substrates by agalacto human chorionic gonadotropin, comprising 29 nM for ß4GalNAc-T3 and 1.2 µM for ß4GalNAc-T4. Our in vitro analysis indicates that enzymatic recognition of the peptide determinant and the oligosaccharide acceptor are independent events.
Assuntos
Acetilglucosamina/química , Anidrases Carbônicas/química , Gonadotropina Coriônica/química , Hormônio Luteinizante/química , N-Acetilgalactosaminiltransferases/química , Acetilglucosamina/genética , Acetilglucosamina/metabolismo , Animais , Anidrases Carbônicas/genética , Anidrases Carbônicas/metabolismo , Catálise , Gonadotropina Coriônica/genética , Gonadotropina Coriônica/metabolismo , Células HEK293 , Humanos , Hormônio Luteinizante/genética , Hormônio Luteinizante/metabolismo , Camundongos , N-Acetilgalactosaminiltransferases/genética , N-Acetilgalactosaminiltransferases/metabolismo , Proteínas Recombinantes de Fusão/química , Proteínas Recombinantes de Fusão/genética , Proteínas Recombinantes de Fusão/metabolismoRESUMO
N- and O-linked oligosaccharides on pro-opiomelanocortin both bear the unique terminal sequence SO(4)-4-GalNAcß1,4GlcNAcß. We previously demonstrated that protein-specific transfer of GalNAc to N-linked oligosaccharides on glycoprotein substrates is dependent on the presence of both an oligosaccharide acceptor and a peptide recognition motif consisting of a cluster of basic amino acids. We characterized how two ß1,4-N-acetylgalactosaminyltransferases, ß4GalNAc-T3 and ß4GalNAc-T4, require the presence of both the peptide recognition motif and the N-linked oligosaccharide acceptors to transfer GalNAc in ß1,4-linkage to GlcNAc in vivo and in vitro. We now show that ß4GalNAc-T3 and ß4GalNAc-T4 are able to utilize the same peptide motif to selectively add GalNAc to ß1,6-linked GlcNAc in core 2 O-linked oligosaccharide structures to form Galß1,3(GalNAcß1,4GlcNAcß1,6)GalNAcαSer/Thr. The ß1,4-linked GalNAc can be further modified with 4-linked sulfate by either GalNAc-4-sulfotransferase 1 (GalNAc-4-ST1) (CHST8) or GalNAc-4-ST2 (CHST9) or with α2,6-linked N-acetylneuraminic acid by α2,6-sialyltransferase 1 (ST6Gal1), thus generating a family of unique GalNAcß1,4GlcNAcß (LacdiNAc)-containing structures on specific glycoproteins.
Assuntos
Acetilglucosamina/química , Glicoproteínas/química , N-Acetilgalactosaminiltransferases/química , Peptídeos/química , Acetilglucosamina/genética , Acetilglucosamina/metabolismo , Animais , Antígenos CD/química , Antígenos CD/genética , Antígenos CD/metabolismo , Células CHO , Cricetinae , Cricetulus , Glicoproteínas/genética , Glicoproteínas/metabolismo , Glicosilação , Células HEK293 , Humanos , Camundongos , N-Acetilgalactosaminiltransferases/genética , N-Acetilgalactosaminiltransferases/metabolismo , Peptídeos/genética , Peptídeos/metabolismo , Sialiltransferases/química , Sialiltransferases/genética , Sialiltransferases/metabolismo , Sulfotransferases/química , Sulfotransferases/genética , Sulfotransferases/metabolismoRESUMO
A limited number of glycoproteins including luteinizing hormone and carbonic anhydrase-VI (CA6) bear N-linked oligosaccharides that are modified with beta1,4-linked N-acetylgalactosamine (GalNAc). The selective addition of GalNAc to these glycoproteins requires that the beta1,4-N-acetylgalactosaminyltransferase (betaGT) recognize both the oligosaccharide acceptor and a peptide recognition determinant on the substrate glycoprotein. We report here that two recently cloned betaGTs, betaGT3 and betaGT4, that are able to transfer GalNAc to GlcNAc in beta1,4-linkage display the necessary glycoprotein specificity in vivo. Both betaGTs transfer GalNAc to N-linked oligosaccharides on the luteinizing hormone alpha subunit and CA6 but not to those on transferrin (Trf). A single peptide recognition determinant encoded in the carboxyl-terminal 19-amino acid sequence of bovine CA6 mediates transfer of GalNAc to each of its two N-linked oligosaccharides. The addition of this 19-amino acid sequence to the carboxyl terminus of Trf confers full acceptor activity onto Trf for both betaGT3 and betaGT4 in vivo. The complete 19-amino acid sequence is required for optimal GalNAc addition in vivo, indicating that the peptide sequence is both necessary and sufficient for recognition by betaGT3 and betaGT4.
Assuntos
Acetilglucosamina/metabolismo , Anidrases Carbônicas/metabolismo , Hormônio Luteinizante/metabolismo , N-Acetilgalactosaminiltransferases/metabolismo , Modificação Traducional de Proteínas/fisiologia , Acetilglucosamina/genética , Anidrases Carbônicas/genética , Linhagem Celular , Glicoproteínas/genética , Glicoproteínas/metabolismo , Glicosilação , Humanos , Hormônio Luteinizante/genética , N-Acetilgalactosaminiltransferases/genética , Oligossacarídeos/genética , Oligossacarídeos/metabolismo , Peptídeos/genética , Peptídeos/metabolismo , Especificidade por Substrato/fisiologia , Transferrina/genética , Transferrina/metabolismoRESUMO
Sorting protein-related receptor (SorLA/LR11) is a highly conserved mosaic receptor that is expressed by cells in a number of different tissues including principal cells of the collecting ducts in the kidney and neurons in the central and peripheral nervous systems. SorLA/LR11 has features that indicate it serves as a sorting receptor shuttling between the plasma membrane, endosomes, and the Golgi. We have found that a fraction of SorLA/LR11 that is synthesized in the kidney and the brain bears N-linked oligosaccharides that are modified with terminal beta1,4-linked GalNAc-4-SO(4). Oligosaccharides located in the vacuolar sorting (Vps) 10p domain (Vps10p domain) are modified with beta1,4-linked GalNAc when the Vps10p domain is expressed in cells along with either of two recently cloned protein-specific beta1,4GalNAc-transferases, GalNAcTIII and GalNAcTIV. Either of two sequences with basic amino acids located within the Vps10p domain is able to mediate recognition by these beta1,4GalNAc-transferases. The highly specific modification of oligosaccharides in the Vps10p domain of SorLA/LR11 with terminal GalNAc-4-SO(4) suggests that this unusual modification may modulate the interaction of SorLA/LR11 with proteins and influence their trafficking.